文献速递糖尿病

二甲双胍使用与老年2型糖尿病患者谵妄风险

Metformin Use and Risk of Delirium in Older Adults With Type 2 Diabetes.
PubMed 文献 · Diabetes Care · 2025-01-01

本研究比较66,568例二甲双胍使用者与倾向评分匹配的66,568例非使用者,采用多变量Cox回归及Fine和Gray方法评估谵妄与死亡风险。二甲双胍使用与谵妄风险显著降低相关,校正风险比为0.77至0.81,并观察到累积剂量和日剂量越高谵妄风险降低越明显的剂量反应关系。

要点

  • 二甲双胍使用与老年2型糖尿病患者谵妄风险显著降低相关,校正HR为0.77至0.81。
  • 二甲双胍累积剂量和日剂量越高,谵妄风险降低越明显,呈剂量反应关系。
  • 研究采用竞争风险分析(Fine和Gray方法)处理死亡竞争事件,以更准确评估谵妄风险。

核心结论

  • 二甲双胍使用与老年2型糖尿病患者谵妄风险降低相关,且剂量越高保护作用越强。

研究设计与样本

  • 研究比较二甲双胍使用者与倾向评分匹配的非使用者队列,共纳入66,568例二甲双胍使用者和66,568例非使用者。
  • 采用多变量Cox回归和Fine和Gray方法评估谵妄与死亡风险。

主要发现

  • 二甲双胍使用与谵妄风险显著降低相关,校正风险比为0.77至0.81。
  • 观察到剂量反应关系,较高的二甲双胍累积剂量和日剂量与谵妄风险更大幅度的降低相关。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Delirium is a precursor and risk factor for dementia, emphasizing the urgency of effective prevention and management strategies in older adults with type 2 diabetes (T2D). Identifying long-term, safe, and effective medications to prevent diabetes-related delirium is crucial because of its significant impact on this population. This study aimed to evaluate the protective effects of metformin against delirium in older adults with T2D, using a competing risk analysis of death to provide a more accurate assessment. RESEARCH DESIGN AND METHODS: Metformin users were compared with a cohort of nonusers. Multivariable Cox regression and Fine and Gray methods were used to assess the risk of delirium and mortality. RESULTS: Our study included 66,568 metformin users and 66,568 nonusers, matched by propensity score. The use of metformin was associated with a significantly lower risk of delirium, with adjusted hazard ratios ranging from 0.77 to 0.81. A dose-response relationship was observed, indicating that higher cumulative and daily doses of metformin were associated with greater reductions in delirium risk. CONCLUSIONS: Metformin use is associated with a reduced risk of delirium in older adults with T2D, with higher doses offering greater protection.

来源:Diabetes Care,查看原文。版权归原作者所有。

引用

  1. Sun M, Wang X, Lu Z, et al. Metformin Use and Risk of Delirium in Older Adults With Type 2 Diabetes. Diabetes Care. 2025. PMID: 39361020. doi:10.2337/dc24-1414

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。